Developing moral AI to support decision-making about antimicrobial use

  16 November 2022

The use of decision-support systems based on artificial intelligence approaches in antimicrobial prescribing raises important moral questions. Adopting ethical frameworks alongside such systems can aid the consideration of infection-specific complexities and support moral decision-making to tackle antimicrobial resistance.

The development and adoption of AI-based decision-support tools to support improved antimicrobial use raises significant moral questions. Most notably, antimicrobial prescribing decision-support systems must, we argue, achieve a moral balance between the needs of an individual patient and those of the wider and future society.

Author(s): William J. Bolton, Cosmin Badea, Pantelis Georgiou, Alison Holmes & Timothy M. Rawson
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!